Total Payments
$227,824
2024 Payments
$15,799
Companies
8
Transactions
92
Medicare Patients
1,577
Medicare Billing
$135,895
Payment Breakdown by Category
Other$101,873 (44.7%)
Consulting$75,889 (33.3%)
Travel$39,570 (17.4%)
Research$8,025 (3.5%)
Food & Beverage$2,441 (1.1%)
Education$25.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $101,873 | 20 | 44.7% |
| Consulting Fee | $75,889 | 10 | 33.3% |
| Travel and Lodging | $39,570 | 32 | 17.4% |
| Unspecified | $8,025 | 4 | 3.5% |
| Food and Beverage | $2,441 | 25 | 1.1% |
| Education | $25.00 | 1 | 0.0% |
Payments by Type
General
$219,798
88 transactions
Research
$8,025
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $91,919 | 15 | $0 (2023) |
| GENZYME CORPORATION | $78,601 | 33 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $51,416 | 35 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $5,452 | 2 | $0 (2023) |
| AbbVie, Inc. | $195.74 | 3 | $0 (2019) |
| LEO Pharma Inc. | $120.17 | 2 | $0 (2023) |
| PFIZER INC. | $83.30 | 1 | $0 (2018) |
| Janssen Scientific Affairs, LLC | $36.44 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,799 | 4 | GENZYME CORPORATION ($14,518) |
| 2023 | $111,319 | 39 | GENZYME CORPORATION ($53,673) |
| 2022 | $60,231 | 23 | SANOFI-AVENTIS U.S. LLC ($37,861) |
| 2021 | $2,480 | 1 | Regeneron Healthcare Solutions, Inc. ($2,480) |
| 2020 | $11,070 | 7 | Regeneron Healthcare Solutions, Inc. ($11,070) |
| 2019 | $17,563 | 10 | Regeneron Healthcare Solutions, Inc. ($14,921) |
| 2018 | $5,662 | 6 | SANOFI-AVENTIS U.S. LLC ($5,502) |
| 2017 | $3,698 | 2 | SANOFI-AVENTIS U.S. LLC ($3,666) |
All Payment Transactions
92 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $3,416.00 | General |
| Category: Immunology | ||||||
| 08/08/2024 | Regeneron Healthcare Solutions, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $427.00 | General |
| 04/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $11,102.00 | General |
| Category: Immunology | ||||||
| 04/04/2024 | Regeneron Healthcare Solutions, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $854.00 | General |
| 12/19/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: Immunology | ||||||
| 11/06/2023 | LEO Pharma Inc. | — | Education | In-kind items and services | $25.00 | General |
| 11/05/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $500.00 | General |
| Category: Immunology | ||||||
| 11/05/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $250.00 | General |
| Category: Immunology | ||||||
| 11/03/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $11,368.00 | General |
| Category: Immunology | ||||||
| 11/03/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $102.00 | General |
| Category: Immunology | ||||||
| 11/03/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $100.77 | General |
| Category: Immunology | ||||||
| 11/03/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $48.09 | General |
| Category: Immunology | ||||||
| 11/03/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $31.45 | General |
| Category: Immunology | ||||||
| 11/03/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: Immunology | ||||||
| 11/03/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.88 | General |
| Category: Immunology | ||||||
| 10/21/2023 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $28,003.00 | General |
| Category: Immunology | ||||||
| 10/21/2023 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $9,092.75 | General |
| Category: Immunology | ||||||
| 10/21/2023 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $1,633.43 | General |
| Category: Immunology | ||||||
| 10/21/2023 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $1,524.53 | General |
| Category: Immunology | ||||||
| 10/21/2023 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $686.04 | General |
| Category: Immunology | ||||||
| 10/19/2023 | Regeneron Healthcare Solutions, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,487.00 | General |
| 10/19/2023 | Regeneron Healthcare Solutions, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $713.00 | General |
| 10/17/2023 | Regeneron Healthcare Solutions, Inc. | — | Travel and Lodging | In-kind items and services | $334.80 | General |
| 10/14/2023 | Regeneron Healthcare Solutions, Inc. | — | Travel and Lodging | In-kind items and services | $359.80 | General |
| 08/19/2023 | Regeneron Healthcare Solutions, Inc. | — | Travel and Lodging | In-kind items and services | $407.10 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized, Double-Blind, Placebo-Controlled, Sequential Ascending, Repeated-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous REGN668 in Patients With Moderate-to-Severe | SANOFI-AVENTIS U.S. LLC | $5,502 | 3 |
| DUPIXENT CLINICAL DEVELOPMENT PROGRAM | Regeneron Pharmaceuticals, Inc. | $2,524 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 319 | 595 | $250,998 | $27,265 |
| 2022 | 13 | 493 | 909 | $393,133 | $45,430 |
| 2021 | 13 | 439 | 839 | $350,196 | $42,148 |
| 2020 | 11 | 326 | 564 | $211,171 | $21,051 |
Total Patients
1,577
Total Services
2,907
Medicare Billing
$135,895
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 208 | $120,016 | $15,960 | 13.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 60 | $23,580 | $3,263 | 13.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $26,010 | $2,847 | 10.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 23 | 32 | $22,368 | $1,830 | 8.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 35 | 43 | $20,038 | $1,773 | 8.8% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 14 | 21 | $7,056 | $490.84 | 7.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 15 | 20 | $13,421 | $430.11 | 3.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 14 | 14 | $11,328 | $405.40 | 3.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 27 | 167 | $7,181 | $266.13 | 3.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 283 | $163,291 | $23,722 | 14.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 107 | $42,051 | $5,787 | 13.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $41,616 | $5,273 | 12.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 44 | 67 | $31,222 | $3,017 | 9.7% |
| 11901 | Injection into skin growth, more than 7 growths | Office | 2022 | 16 | 39 | $15,951 | $1,512 | 9.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 19 | 21 | $14,679 | $1,118 | 7.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $8,625 | $1,102 | 12.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 34 | 43 | $27,520 | $1,059 | 3.8% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 23 | 25 | $19,925 | $908.33 | 4.6% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 20 | 32 | $10,752 | $777.01 | 7.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 13 | 19 | $4,579 | $564.11 | 12.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 30 | 196 | $8,428 | $336.53 | 4.0% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 11 | 14 | $4,494 | $254.20 | 5.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 115 | 232 | $133,864 | $19,730 | 14.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 131 | $51,483 | $7,407 | 14.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 41 | 41 | $35,547 | $5,014 | 14.1% |
About Dr. Timothy Berger, MD
Dr. Timothy Berger, MD is a Dermatology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124079181.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Berger, MD has received a total of $227,824 in payments from pharmaceutical and medical device companies, with $15,799 received in 2024. These payments were reported across 92 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($101,873).
As a Medicare-enrolled provider, Berger has provided services to 1,577 Medicare beneficiaries, totaling 2,907 services with total Medicare billing of $135,895. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatopathology
- Location San Francisco, CA
- Active Since 05/15/2006
- Last Updated 06/10/2008
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1124079181
Products in Payments
- DUPIXENT (Biological) $154,341
- DUPIXENT (Drug) $9,168
- Humira (Biological) $195.74
- ADBRY (Biological) $95.17
- EUCRISA (Drug) $83.30
- TREMFYA (Drug) $36.44
- DERMATITIS - DISEASE (Drug) $32.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in San Francisco
Dr. John Koo, Md, MD
Dermatology — Payments: $3.5M
Dermatology $3.5M
Dr. Mary Spellman, M.d, M.D
Dermatology — Payments: $756,356
Dermatology $756,356
Tina Bhutani-Jacques, Md, MD
Dermatology — Payments: $472,684
Dermatology $472,684
Dr. Michael Rosenblum, M.d., Ph.d, M.D., PH.D
Dermatology — Payments: $312,856
Dermatology $312,856
Dr. Howard Maibach, M.d, M.D
Dermatology — Payments: $272,402
Dermatology $272,402
Dr. Sarina Elmariah, M.d, Ph.d, M.D, PH.D
Dermatology — Payments: $231,513
Dermatology $231,513